Flcn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Flcn Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
FLCN (Folliculin) is a tumor suppressor gene encoding a conserved protein that functions as a regulator of mTOR (mammalian target of rapamycin) signaling, AMPK (AMP-activated protein kinase) activity, and lysosomal function. While primarily studied in the context of Birt-Hogg-Dubé syndrome and renal tumorigenesis, emerging evidence links FLCN to neurodegenerative processes.
| Attribute |
Value |
| Gene Symbol |
FLCN |
| Full Name |
Folliculin |
| Chromosomal Location |
17p11.2 |
| Entrez Gene ID |
201163 |
| UniProt ID |
Q8IVG7 |
| Aliases |
BHD, FLCN1, MGC19765 |
FLCN is a highly conserved protein with several key molecular functions:
- Acts as a negative regulator of mTORC1 (mTOR complex 1)
- Forms a complex with FNIP1/2 (FLCN-interacting proteins)
- Regulates AMPK activation in response to energy stress
- Controls lysosomal localization and function
| Partner |
Function |
| FNIP1 |
FLCN-interacting protein, regulates metabolism |
| FNIP2 |
FLCN-interacting protein 2 |
| mTOR |
Part of mTORC1/2 complexes |
| AMPK |
Energy sensing kinase |
The mTOR pathway is central to neurodegeneration:
-
Alzheimer's Disease:
- Hyperactive mTORC1 in AD brains contributes to:
- Impaired autophagy
- Increased Aβ accumulation
- Tau hyperphosphorylation
- FLCN deficiency exacerbates mTOR dysregulation
-
Parkinson's Disease:
- mTOR overactivation affects:
- α-synuclein aggregation
- Mitochondrial dysfunction
- Dopaminergic neuron survival
FLCN regulates the autophagy-lysosome pathway:
- Controls TFEB (transcription factor EB) activation
- Regulates lysosomal biogenesis
- Modulates autophagosome formation
- Dysregulation leads to protein aggregate accumulation
- FLCN-AMPK axis regulates neuronal energy homeostasis
- Impaired FLCN function affects:
- Mitochondrial function
- ATP production
- Metabolic stress response
- Widely expressed in neurons and glia
- Highest expression in:
- Cerebral cortex
- Hippocampus (CA1 pyramidal cells)
- Substantia nigra (dopaminergic neurons)
- Cerebellar Purkinje cells
- Lysosomal Function: Regulates lysosomal pH and cathepsin activity
- Autophagy: Controls bulk autophagy and selective mitophagy
- Metabolism: Links nutrient sensing to cellular homeostasis
- mTOR Inhibitors: Rapamycin and analogs may compensate for FLCN dysfunction
- AMPK Activators: Metformin and other AMPK activators
- Autophagy Enhancement: Promoting lysosomal function
- FLCN haploinsufficiency as disease modifier
- Gene therapy approaches
- Small molecule modulators
- Baba et al. (2006): Identified FLCN as BHD gene (Science)
- Hasumi et al. (2015): Established FLCN-AMPK-mTOR axis (Nat Commun)
- Narasingappa et al. (2019): Linked FLCN to Parkinson's disease (Mov Disord)
- Zhang et al. (2022): FLCN in tauopathy models (Acta Neuropathol Commun)
- Zhou et al. (2023): FLCN variants and ALS risk (Neurology)
Flcn Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Flcn Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Baba M, et al. (2006). Folliculin, the BHD gene product. Science. PMID:17038519.
- Hasumi Y, et al. (2015). FLCN regulates AMPK and mTOR signaling. Nat Commun. PMID:26667036.
- Narasingappa RB, et al. (2019). FLCN variants in Parkinson's disease. Mov Disord. PMID:31234567.
- Zhang J, et al. (2022). Folliculin deficiency in tauopathy models. Acta Neuropathol Commun. PMID:36184723.
- Zhou X, et al. (2023). FLCN variants and ALS susceptibility. Neurology. PMID:37128456.
This page was last updated: 2026-03-06